// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Vascular Endothelial Growth Factor Myocardial Cell Anti-apoptotic Events Requires S100A6 Signaling

Ioannis K Rizos - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Vancouver General Hospital Pericardial Effusion Risk Index

Ken Gin - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dyspnea

N/A

Single Right Ventricle Hearts Had Similar Total and Apical Intraventricular Pressure Gradient/Ventricular Suction/to Single Left Ventricle Hearts From Birth to Post Fontan

Kana Ohno - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Impact of Complete Revascularization in Acute Coronary Syndromes: Insights From the Alberta Contemporary Acute Coronary Syndrome Patients Invasive Treatment Strategies (COAPT) Registry

Padma Kaul - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Acute Coronary Syndromes

N/A

Reduction of Neointimal Hyperplasia With Clopidogrel or Ticagrelor in a Canine Model of Coronary Stent Implantation

Josep Rodes-Cabau - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Clopidogrel bisulfate

Identification of Aortic Tissue at Risk for Dysfunction in Patients With Aortopathy Using 4D Flow MRI: Impact of Surgical Intervention

Paul W.M. Fedak - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Functional Mitral Stenosis After Mitral Valve Repair: Comparison of Complete Ring With Posterior Band

Karen Hay - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Mitral stenosis

N/A

The Immature Right Ventricle Has Impaired Fatty Acid Metabolic Flexibility During Acute Physiologic Stressors

Nuri Muhammad - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

N/A

Effect of Somah Solution on Hypoxia/Reoxygenation Induced Coronary Artery Endothelial Injury: A Comparison to Current Ex-Vivo Heart Perfusates

Hiroyuki Kawajiri - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ischemia-reperfusion injury

endothelin-1

Cardiac Resynchronization Therapy After Prophylactic Epicardial Leads Implantation During Concomitant Cardiac Surgery: Impact on Left Ventricular Remodeling and Clinical Outcomes

Aude Marceau - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Surgical Atrial Fibrillation Ablation: a Systematic Review and Meta-analysis of Randomized Controlled Trials

Emilie P Belley-Cote - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

N/A

Acute Pharmacological Inhibition of PI3K? by the Novel Cancer Drug, BYL-719, Has a Pro-arrhythmic Effect

Brent McLean - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Phosphatidylinositol

Congestive Heart Failure Upregulates Volume-Dependent Chloride Currents in c-Kit+ Endogenous Cardiac Stem Cells

Patrice Naud - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Trends in the Management of Acute Type A Intramural Hematoma

Kevin M Harris - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Aortic intramural hematoma

N/A

Atrial Fibrillation Complicating Non-Cardiothoracic Surgery (POAF) is Associated With Increased Mortality and Stroke: A Systematic Review

Karan Bami - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Predicting Appropriate Shocks In Patients With Heart Failure: Patient Level Meta-analysis From SCD-HeFT and Madit II

Sana M. Al-Khatib - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Riata Lead Failure in Pediatric and Congenital Heart Disease Patients

Sunjidatul Islam - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congenital heart disease

N/A

Distinctive Functions of PI3K? in Endothelial Cells and Cardiomyocytes in Response to Myocardial Infarction: Complications for Targeting PI3K? in Myocardial Infarction Treatment

Pavel Zhabyeyev - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

Tamoxifen

ApoC3-Gln38Lys Variant is a Gain-of-function Mutation Associated With Human Hypertriglyceridemia

Meenakshi Sundaram - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Dyslipidemia

N/A

New York Heart Association Class and the Mortality Benefit From Primary Prevention Implantable Cardioverter Defibrillator Use: A Pooled Analysis of 4 Randomized Control Trials

Sana M Al-Khatib - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Advanced heart failure

N/A

Copyright © 2026. QuantiNova All rights reserved